In adults who had not had COVID-19, Novavax vaccine had 90% efficacy at >/=7 d after the second dose. Granwehr BP. Ann Intern Med 2022 May 3. doi: 10.7326/J22-0028.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Granwehr BP. In adults who had not had COVID-19, Novavax vaccine had 90% efficacy at >/=7 d after the second dose. Ann Intern Med 2022 May 3. doi: 10.7326/J22-0028.
PMID: 35500261